Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Accepted on 23 Apr 2025

Iodine-131 Induces Ferroptosis and Synergizes with Sulfasalazine in Differentiated Thyroid Cancer Cells via Suppressing SLC7A11

in Pharmacology of Anti-Cancer Drugs

Li Ling
JH Zhang
Xiao Zhang
Peiqi Wang
Mingjun Ma
Bingling Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1580828

Case Report

Published on 22 Apr 2025

Potential synergistic effects of lenvatinib and aspirin in aortic dissection: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Lan Luo
Hao Liang
Lin Yuan
Ya-Kun Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1520770

125 views

Case Report

Accepted on 21 Apr 2025

Laser speckle flowgraphy in a patient with uveitis due to immune-related adverse events by immune checkpoint inhibitors

in Pharmacology of Anti-Cancer Drugs

Satoru Kase
Yui Yamashita
Satoshi Takeuchi
Susumu Ishida

Frontiers in Oncology

doi 10.3389/fonc.2025.1492011

Original Research

Accepted on 21 Apr 2025

Development of CSOARG: A Single-Cell and Multi-Omics-Based Machine Learning Model for Ovarian Cancer Prognosis and Drug Response Prediction

in Pharmacology of Anti-Cancer Drugs

Junyu Chen
Bin Guan
Jihong Zhang
Xin LI
Jingyi Fang
Wencai Guan
Qi Lu
Guoxiong Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592426

Original Research

Accepted on 21 Apr 2025

Aurintricarboxylic Acid Inhibits the Malignant Phenotypes of Drug-Resistant Cells via Translational Regulation

in Pharmacology of Anti-Cancer Drugs

Keke Shang
Yang Chen
Jingjie Jin
Tong Wang
Gong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1576685

Review

Accepted on 21 Apr 2025

Application of Bifidobacterium in Tumor Therapy

in Pharmacology of Anti-Cancer Drugs

银武孔
前艳李
莉常
晗柏
菲菲邓

Frontiers in Oncology

doi 10.3389/fonc.2025.1551924

Case Report

Published on 16 Apr 2025

A case report of a spherical mass in the right atrium: myxoma or thrombus?

in Pharmacology of Anti-Cancer Drugs

Yulian Wu
Xidan Wang
Daoling Yang
Xiaoying Tao

Frontiers in Oncology

doi 10.3389/fonc.2025.1581972

242 views

Systematic Review

Published on 16 Apr 2025

Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Bin Liu
Jie Chen
Mingqi Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1513774

299 views

Original Research

Accepted on 14 Apr 2025

Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer: Indirect Comparison of Different ALK Inhibitors Using Reconstructed Patient Data

in Pharmacology of Anti-Cancer Drugs

Vera Damuzzo
Lorenzo Gasperoni
Luna Del Bono
Andrea Ossato
Alessandro Inno
Andrea Messori

Frontiers in Oncology

doi 10.3389/fonc.2025.1566816

141 views

Original Research

Published on 14 Apr 2025

Targeting the dual miRNA/BMP2 network: LncRNA H19-mediated temozolomide resistance unveils novel therapeutic strategies in glioblastoma

in Pharmacology of Anti-Cancer Drugs

Qiudan Chen
Shihao Zhuang
Shuying Chen
Biying Wu
Qingyu Zhou
Weifeng Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1577221

334 views

Original Research

Accepted on 11 Apr 2025

Cell-In-Cell-Associated lncRNA Signature Predicts Prognosis and the Immune Response in Gastric Cancer

in Pharmacology of Anti-Cancer Drugs

Junzuo Lin
Liancheng Wu
Zhengfei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1597187

Original Research

Accepted on 11 Apr 2025

PCDH1 Coordinates Dual Mechanisms in Pancreatic Ductal Adenocarcinoma: Stemness Association and PI3K/Akt-Mediated Progression

in Pharmacology of Anti-Cancer Drugs

Zhiqiang Yang
Zhang Zhipeng
Ye Song
Chuang Dai
Weihui Zhang
Dali Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1593281

105 views

Original Research

Accepted on 10 Apr 2025

Analysis of three treatment methods for granulomatous lobular mastitis: A retrospective study in a single center

in Pharmacology of Anti-Cancer Drugs

Boyu Shang
Tianyi Zhang
Chang Liu
Jiaxin Lu
Can Cui
Jing Feng
Yi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1588836

Original Research

Published on 10 Apr 2025

Predictive significance of 18F-FDG PET/CT metabolic parameters for the expression level of HER2 in gastric cancer

in Pharmacology of Anti-Cancer Drugs

Zhang Shilai
Mo Shaozhou
Wei Linlin
Chai Hua
Pu Weiwei
Liu Ziya
Qiu Wenming
Yang Zhi
Liao Hai
Xiao Guoyou

Frontiers in Oncology

doi 10.3389/fonc.2025.1580166

251 views

Original Research

Published on 09 Apr 2025

Acute aerobic exercise alters serum protein distribution in colorectal cancer patients

in Pharmacology of Anti-Cancer Drugs

Sinan Jin
Shude Han
Ning Wang
Mingrui Yang
Chao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1586344

301 views

Case Report

Published on 02 Apr 2025

Anlotinib induced type 1 diabetes: a case report

in Pharmacology of Anti-Cancer Drugs

Jing Chen
Daohan Xia
Linqiu Ke

Frontiers in Oncology

doi 10.3389/fonc.2025.1508645

470 views